Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Heyse

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Experimental Parasitology|October 20, 2000
Efficacy estimates from parasite count data that include zero countsJ L Cox, J F Heyse, J W Tukey
Journal of the National Cancer Institute|June 1, 1984
Design of cancer assays for pharmaceutical agentsJ L Ciminera, J F Heyse, N Mantel, et al.
Toxicology and Applied Pharmacology|December 1, 1987
Interactions between caffeine and adenosine agonists in producing embryo resorptions and malformations in miceR L Clark, K Eschbach, W A Cusick, et al.
Statistics in Medicine|June 15, 1993
Evaluation of multicentre clinical trial data using adaptations of the Mosteller-Tukey procedureJ L Ciminera, J F Heyse, H H Nguyen, et al.
Statistics in Medicine|June 15, 1993
Tests for qualitative treatment-by-centre interaction using a 'pushback' procedureJ L Ciminera, J F Heyse, H H Nguyen, et al.
Journal of Clinical Epidemiology|October 1, 1993
Time-dependent variability in repeated measurements of cholesterol levels: clinical implications for risk misclassification and intervention monitoringJ R Roeback, J R Cook, H A Guess, et al.
The Urologic Clinics of North America|November 1, 1993
Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trialH A Guess, J F Heyse, G J Gormley, et al.
Journal of Biopharmaceutical Statistics|August 9, 2006
Statistical considerations for noninferiority/equivalence trials in vaccine developmentW W B Wang, D V Mehrotra, I S F Chan, et al.
International Journal of Technology Assessment in Health Care|January 1, 1992
A model for evaluating the cost-effectiveness of cholesterol-lowering treatmentH Glick, J F Heyse, D Thompson, et al.
Circulation|April 15, 1995
Cholesterol reduction yields clinical benefit. A new look at old dataA L Gould, J E Rossouw, N C Santanello, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Experimental Parasitology|October 20, 2000
Efficacy estimates from parasite count data that include zero countsJ L Cox, J F Heyse, J W Tukey
Journal of the National Cancer Institute|June 1, 1984
Design of cancer assays for pharmaceutical agentsJ L Ciminera, J F Heyse, N Mantel, et al.
Toxicology and Applied Pharmacology|December 1, 1987
Interactions between caffeine and adenosine agonists in producing embryo resorptions and malformations in miceR L Clark, K Eschbach, W A Cusick, et al.
Statistics in Medicine|June 15, 1993
Evaluation of multicentre clinical trial data using adaptations of the Mosteller-Tukey procedureJ L Ciminera, J F Heyse, H H Nguyen, et al.
Statistics in Medicine|June 15, 1993
Tests for qualitative treatment-by-centre interaction using a 'pushback' procedureJ L Ciminera, J F Heyse, H H Nguyen, et al.
Journal of Clinical Epidemiology|October 1, 1993
Time-dependent variability in repeated measurements of cholesterol levels: clinical implications for risk misclassification and intervention monitoringJ R Roeback, J R Cook, H A Guess, et al.
The Urologic Clinics of North America|November 1, 1993
Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trialH A Guess, J F Heyse, G J Gormley, et al.
Journal of Biopharmaceutical Statistics|August 9, 2006
Statistical considerations for noninferiority/equivalence trials in vaccine developmentW W B Wang, D V Mehrotra, I S F Chan, et al.
International Journal of Technology Assessment in Health Care|January 1, 1992
A model for evaluating the cost-effectiveness of cholesterol-lowering treatmentH Glick, J F Heyse, D Thompson, et al.
Circulation|April 15, 1995
Cholesterol reduction yields clinical benefit. A new look at old dataA L Gould, J E Rossouw, N C Santanello, et al.
Pageof 3